Peripheral artery disease: epidemiology and global perspectives
FGR Fowkes, V Aboyans, FJI Fowkes… - Nature Reviews …, 2017 - nature.com
Global populations are undergoing a major epidemiological transition in which the burden of
atherosclerotic cardiovascular diseases is shifting rapidly from high-income to low-income …
atherosclerotic cardiovascular diseases is shifting rapidly from high-income to low-income …
Epidemiology of peripheral artery disease
New data on the epidemiology of peripheral artery disease (PAD) are available, and they
should be integrated with previous data. We provide an updated, integrated overview of the …
should be integrated with previous data. We provide an updated, integrated overview of the …
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive …
AT Hirsch, ZJ Haskal, NR Hertzer, CW Bakal… - Journal of the American …, 2006 - jacc.org
These guidelines address the diagnosis and management of atherosclerotic, aneurysmal,
and thromboembolic peripheral arterial diseases (PADs). The clinical manifestations of PAD …
and thromboembolic peripheral arterial diseases (PADs). The clinical manifestations of PAD …
Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities
RM Adibhatla, JF Hatcher - Antioxidants & redox signaling, 2010 - liebertpub.com
Reactive oxygen species (ROS) are produced at low levels in mammalian cells by various
metabolic processes, such as oxidative phosphorylation by the mitochondrial respiratory …
metabolic processes, such as oxidative phosphorylation by the mitochondrial respiratory …
Homocysteine and age-associated disorders
EA Ostrakhovitch, S Tabibzadeh - Ageing research reviews, 2019 - Elsevier
There are numerous theories of aging, a process which still seems inevitable. Aging leads to
cancer and multi-systemic disorders as well as chronic diseases. Decline in age-associated …
cancer and multi-systemic disorders as well as chronic diseases. Decline in age-associated …
[HTML][HTML] The controversy over homocysteine and cardiovascular risk
PM Ueland, H Refsum, SAA Beresford… - The American journal of …, 2000 - Elsevier
Elevated plasma total homocysteine (tHcy) is a risk factor for occlusive cardiovascular
disease (CVD). This concept is based on the observations of premature vascular disease in …
disease (CVD). This concept is based on the observations of premature vascular disease in …
Risk factors for progression of peripheral arterial disease in large and small vessels
Background—Data on the natural history of peripheral arterial disease (PAD) are scarce and
are focused primarily on clinical symptoms. Using noninvasive tests, we assessed the role of …
are focused primarily on clinical symptoms. Using noninvasive tests, we assessed the role of …
Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study.
G Premalatha, S Shanthirani, R Deepa… - Diabetes …, 2000 - Am Diabetes Assoc
OBJECTIVE: The epidemiology of peripheral vascular disease has rarely been studied in
non-European populations. The purpose of this study was to determine the prevalence and …
non-European populations. The purpose of this study was to determine the prevalence and …
[HTML][HTML] Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study
Background: Few population-based studies have assessed relations between plasma or
serum total homocysteine (tHcy) and all-cause mortality. Objective: Our goal was to study …
serum total homocysteine (tHcy) and all-cause mortality. Objective: Our goal was to study …
Homocysteine: role and implications in atherosclerosis
S Guthikonda, WG Haynes - Current atherosclerosis reports, 2006 - Springer
Hyperhomocysteinemia promotes atherosclerosis and is most commonly caused by B-
vitamin deficiencies, especially folic acid, B 6, and B 12; genetic disorders; certain drugs; …
vitamin deficiencies, especially folic acid, B 6, and B 12; genetic disorders; certain drugs; …